510(k) device
Aurora Surgiscope System
Rebound Therapeutics Corporation · Endoscope, Neurological (GWG, Class II) · First FDA decision Jan 18, 2019, newest Oct 27, 2023Brain tumorsHydrocephalus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
1
Naming "Aurora Surgiscope"
MAUDE reports
0
Brand "Aurora Surgiscope", since 2015
PubMed studies
7
Mentioning "Aurora Surgiscope"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Aurora Surgiscope System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 4 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Aurora Surgiscope", any status and sponsor, newest update first.
Integra LifeSciences CorporationPublic (IART)
NCT04494295 · 500 participants (planned) · Start Oct 23, 2020 · Primary completion Oct 15, 2028
Device: Aurora Surgiscope System · For: Supratentorial Hemorrhage
Sites: Burbank, California; Miami, Florida; Tampa, Florida · 20 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Aurora Surgiscope", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code GWG
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Aurora Surgiscope"[tiab]. The summary above synthesizes these.
- Early minimally invasive intracerebral hemorrhage evacuation: a phase 2a feasibility, safety, and promise of surgical efficacy study.
Kleinig TJ, Abou-Hamden A, Laidlaw J, et al. · J Neurointerv Surg · 2024Clinical Trial, Phase II, Multicenter Study
- Novel Use of the Aurora Surgiscope System for Minimally Invasive Resection of Intraparenchymal Lesions: A Case Series.
Achey RL, Soni P, Kashkoush A, et al. · Oper Neurosurg · 2022
- Minimally Invasive Evacuation of Intracranial Hemorrhages Using the Aurora® Surgiscope System: Preliminary Experience.
Jaikumar V, Lim J, Leasher E, et al. · Oper Neurosurg · 2026
- Minimally Invasive Resection of Intracranial Tumors Using the Aurora Surgiscope System: A Single-Center Experience.
Jaikumar V, Lim J, Hashmi M, et al. · Oper Neurosurg · 2026
- Minimally Invasive Resection of Intraventricular Pilocytic Astrocytoma Using the Aurora Surgiscope in an Adult Patient: Technical Note.
Housley SB, Lim J, Starling RV, et al. · World Neurosurg · 2022Case Reports
- Minimally-invasive resection of deep-seated subcortical and intraventricular lesions using an integrated camera-port system: A retrospective case series.
Briggs RG, Levy D, Chung RS, et al. · PLoS One · 2026Research Support, Non-U.S. Gov't
- An update on current devices for the port technique: A systematic review.
Smith S, Mediratta S, Knight J, et al. · Neurosurg Rev · 2025Systematic Review
Other devices of this type
Also filed under product code GWG.
- cCeLL - In vivoVPIX Medical, Inc. · 510(k) 2026
- QEVO SystemCarl Zeiss Meditec, AG · 510(k) 2023
- Apollo SystemPenumbra, Inc. · 510(k) 2016
- MINOP Disposable Introducer 26FAesculap, Inc. · 510(k) 2014
- KARL STORZ Flexible Video Neuro-EndoscopeKarl Storz SE & CO. KG · 510(k) 2026
- Precision S 4K SinuscopeStryker Endoscopy · 510(k) 2026
- Hydro Irrigation SystemStryker Instruments · 510(k) 2026
- HJY VisualNext 3D Endoscopic Vision SystemHjy Smart Medical Device Co., Ltd. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.